Wilate

Wilate is a combined human coagulation factor VIII and von Willebrand factor concentrate used to manage bleeding disorders. Suitable for intravenous infusion, it supports hemostasis in conditions like hemophilia A and von Willebrand disease. A trusted choice for factor replacement therapy in clinical settings. Prescription required.

Wilate is used to treat and prevent bleeding episodes in patients with hemophilia A, a genetic disorder causing impaired blood clotting. It is also indicated for von Willebrand disease, a condition where blood does not clot properly due to low levels of von Willebrand factor. This medication helps replace missing clotting factors to support normal blood clotting. It may be used before surgery or dental procedures to reduce bleeding risk.

After intravenous administration, Wilate works by increasing levels of factor VIII and von Willebrand factor in the bloodstream. This supports the natural clotting process, helping to control or prevent bleeding episodes. Users may notice reduced bruising or bleeding over time with regular use. Effects vary depending on individual response and the condition being treated.

Wilate should be handled with care and administered by a healthcare professional. Store the product in a cool, dry place away from direct light. Always check the expiration date before use and inspect the vial for particles or discoloration. Follow proper reconstitution and infusion techniques as directed by your provider to ensure safety and effectiveness.

Wilate may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. Combining it with these agents could increase bleeding risk. Always inform your healthcare provider about all medications you are taking. Avoid alcohol and herbal supplements that may influence clotting, unless approved by a medical professional.